Exome Asset Management LLC
- SEC CIK
- 0002011932
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 52
- +7 vs. Q1 2026
- Portfolio value
- $162.1M
- −$7.84M (−4.6%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GHGuardant Health, Inc. | COM | 67,500 | $10.1M | 6.2% | −15,236−18.4% | Reduced | History |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 27,205 | $9.11M | 5.6% | −18,264−40.2% | Reduced | History |
| TGTXTG Therapeutics, Inc. | COM | 164,915 | $9.06M | 5.6% | +164,915 | New | History |
| COGTCogent Biosciences, Inc. | COM | 210,523 | $8.15M | 5.0% | −68,010−24.4% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 88,177 | $6.99M | 4.3% | −21,887−19.9% | Reduced | History |
| LLYEli Lilly & Co | Stock | 5,492 | $6.59M | 4.1% | −1,520−21.7% | Reduced | History |
| ABVXAbivax S.A. | SPONSORED ADS | 46,878 | $6.25M | 3.9% | +46,878 | New | History |
| ALMSAlumis Inc. | COM | 204,418 | $5.75M | 3.5% | −74,758−26.8% | Reduced | History |
| CYTKCytokinetics Inc | COM NEW | 60,056 | $5.12M | 3.2% | −43,662−42.1% | Reduced | History |
| ELVNEnliven Therapeutics, Inc. | COM | 100,203 | $5.09M | 3.1% | −119,888−54.5% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 97,276 | $4.17M | 2.6% | −17,715−15.4% | Reduced | History |
| UNHUnitedHealth Group Inc | Stock | 9,612 | $4.00M | 2.5% | −3,250−25.3% | Reduced | History |
| TXG10x Genomics, Inc. | CL A COM | 102,629 | $3.93M | 2.4% | −51,565−33.4% | Reduced | History |
| NTRANatera, Inc. | COM | 13,800 | $3.75M | 2.3% | −4,850−26.0% | Reduced | History |
| QUREuniQure N.V. | SHS | 81,056 | $3.73M | 2.3% | +81,056 | New | History |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 32,209 | $3.58M | 2.2% | −8,372−20.6% | Reduced | History |
| MAZEMaze Therapeutics, Inc. | COM | 114,692 | $3.42M | 2.1% | +26,182+29.6% | Added | History |
| GLUEMonte Rosa Therapeutics, Inc. | COM | 137,115 | $3.32M | 2.0% | −42,369−23.6% | Reduced | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 166,493 | $3.24M | 2.0% | −48,883−22.7% | Reduced | History |
| ALKSAlkermes plc. | SHS | 61,336 | $3.21M | 2.0% | −22,767−27.1% | Reduced | History |
| LQDALiquidia Corp | COM NEW | 39,224 | $3.13M | 1.9% | −6,572−14.4% | Reduced | History |
| UTHRUnited Therapeutics Corp | COM | 5,410 | $2.93M | 1.8% | −1,643−23.3% | Reduced | History |
| GKOSGLAUKOS Corp | COM | 19,862 | $2.78M | 1.7% | −1,012−4.8% | Reduced | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 32,214 | $2.63M | 1.6% | −13,507−29.5% | Reduced | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 70,500 | $2.62M | 1.6% | −54,560−43.6% | Reduced | History |
| CBIOCrescent Biopharma, Inc. | COM | 127,769 | $2.30M | 1.4% | −25,422−16.6% | Reduced | History |
| AZNAstraZeneca PLC | ADR | 12,045 | $2.25M | 1.4% | +12,045 | New | History |
| BSXBoston Scientific Corp | Stock | 48,347 | $2.06M | 1.3% | 00.0% | Unchanged | History |
| ADAGAdagene Inc. | ADS | 488,293 | $2.05M | 1.3% | −248,552−33.7% | Reduced | History |
| PENPenumbra Inc | COM | 6,300 | $1.99M | 1.2% | 00.0% | Unchanged | History |
| ISRGIntuitive Surgical Inc | COM NEW | 4,908 | $1.95M | 1.2% | −1,450−22.8% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 47,861 | $1.87M | 1.2% | +47,861 | New | History |
| OCULOcular Therapeutix, Inc | COM | 181,588 | $1.78M | 1.1% | +181,588 | New | History |
| EQEquillium, Inc. | COM | 552,956 | $1.77M | 1.1% | +552,956 | New | History |
| ASNDAscendis Pharma A/S | ORD SHS | 6,573 | $1.75M | 1.1% | +6,573 | New | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 184,914 | $1.73M | 1.1% | −49,222−21.0% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 460,067 | $1.73M | 1.1% | −61,401−11.8% | Reduced | History |
| VSTMVerastem, Inc. | COM NEW | 429,041 | $1.64M | 1.0% | −207,659−32.6% | Reduced | History |
| NKTRNektar Therapeutics | COM NEW | 22,417 | $1.56M | 1.0% | +22,417 | New | History |
| CLPTClearPoint Neuro, Inc. | COM | 83,636 | $1.49M | 0.9% | +83,636 | New | History |
| INSMINSMED Inc | COM PAR $.01 | 13,873 | $1.48M | 0.9% | −12,778−47.9% | Reduced | History |
| CAICaris Life Sciences, Inc. | COM | 78,180 | $1.39M | 0.9% | +78,180 | New | History |
| BBIOBridgeBio Pharma, Inc. | COM | 18,359 | $1.37M | 0.8% | −49,133−72.8% | Reduced | History |
| ZBIOZenas BioPharma, Inc. | COM | 52,443 | $1.33M | 0.8% | −28,287−35.0% | Reduced | History |
| NBPNovaBridge Biosciences | SPONSORED ADS | 576,960 | $1.13M | 0.7% | 00.0% | Unchanged | History |
| ESTAEstablishment Labs Holdings Inc. | COM | 13,100 | $1.12M | 0.7% | 00.0% | Unchanged | History |
| RLAYRelay Therapeutics, Inc. | COM | 47,531 | $889.3K | 0.5% | −230,771−82.9% | Reduced | History |
| GERNGeron Corp | COM | 624,046 | $798.8K | 0.5% | +624,046 | New | History |
| DRUGBright Minds Biosciences Inc. | COM NEW | 10,110 | $709.7K | 0.4% | +10,110 | New | History |
| CMPXCompass Therapeutics, Inc. | COM | 276,165 | $604.8K | 0.4% | +276,165 | New | History |
| REPLReplimune Group, Inc. | COM | 40,361 | $446.8K | 0.3% | +40,361 | New | History |
| ABUSArbutus Biopharma Corp | COM | 50,166 | $240.8K | 0.1% | −25,318−33.5% | Reduced | History |
Sold out since Q1 2026 (8)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| ELVElevance Health, Inc. | Stock | 14,677 | $4.30M | 2.5% | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 85,517 | $3.44M | 2.0% | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 159,341 | $2.38M | 1.4% | History |
| SLNOSoleno Therapeutics Inc | COM | 61,673 | $2.06M | 1.2% | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 130,564 | $1.22M | 0.7% | History |
| NXTCNextCure, Inc. | COM NEW | 115,500 | $1.22M | 0.7% | History |
| PALIPalisade Bio, Inc. | COM | 600,000 | $1.05M | 0.6% | History |
| LPCNLipocine Inc. | COM NEW | 60,861 | $486.3K | 0.3% | History |